Stock Rating Upgrade
During the last several trading days the Value Trend Rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) rose significantly from D to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 3/8/24, Sarepta Therapeutics Inc (NASDAQ: SRPT) stock enjoyed a large increase of 3.0%, closing at $124.37. This advance was accompanied by normal trading volume. The stock has performed in line with the market over the last nine months and has declined -2.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, SRPT is expected to be a major Value Builder.
Sarepta Therapeutics has a current Value Trend Rating of B (Positive). This VT Rating rose significantly in recent days from D previously. This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Sarepta Therapeutics has a neutral Power Rating of 52 but a very high Appreciation Score of 91, with the Positive Value Trend Rating the result.
Be the first to comment